Advocacy intelligence hub — real-time data for patient organizations
Zhujiang Hospital — PHASE1, PHASE2
Medical College of Wisconsin — PHASE1
ImmunityBio, Inc. — PHASE2
Eli Lilly and Company — PHASE1
Ruijin Hospital — PHASE2
Washington University School of Medicine — PHASE1
Hospital Universitario Dr. Jose E. Gonzalez — PHASE2
University of Utah — PHASE1
TORL Biotherapeutics, LLC — PHASE1, PHASE2
University of Miami — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Ramya M Ramaswami, M.D.
National Cancer Institute (NCI)
📍 Bethesda, Maryland
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Tracy Batchelor, MD, MPH, MD MPH
Massachusetts General Hospital
📍 BOSTON, MA
Narendranath Epperla, MD, MS, MD
Huntsman Cancer Institute/ University of Utah
📍 COLUMBUS, OH
Ajay Gopal
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
📍 SEATTLE, WA
Shuhua Yi, Dr
Institute of Hematology & Blood Diseases Hospital, Chinese